A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes
A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in...
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
- Dec 27, 2022
Impact of an exercise program in children with inflammatory bowel disease in remission
Ivana Trivić , Sara Sila, Zrinjka Mišak, Tena Niseteo , Ana Tripalo Batoš , Iva Hojsak , Sanja Kolaček Published in Nov 2022, Pediatric...
IBDENC ENC
- Dec 24, 2022
Inflammatory bowel disease-specific findings are common morphological changes
Inflammatory bowel disease-specific findings are common morphological changes in the ileal pouch with ulcerative colitis. Kenichiro...
IBDENC ENC
- Dec 21, 2022
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis....
IBDENC ENC
- Dec 16, 2022
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Gary R...
IBDENC ENC
- Dec 14, 2022
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier. Scott A Jelinsky,...
IBDENC ENC
- Dec 2, 2022
Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases
Catherine Robbe Masselot, Camille Cordier, PharmD, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid Published: 25 November...
IBDENC ENC
- Oct 31, 2022
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. Wei Peng, Xinhua Zhao,...
IBDENC ENC
- Oct 29, 2022
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve
Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Sushma Chowdary...
IBDENC ENC
- Oct 28, 2022
An autologous colonic organoid-derived monolayer model to study immune
An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Hamish CK...
IBDENC ENC
- Oct 25, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and...
IBDENC ENC
- Oct 23, 2022
Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, Randy S Longman, Dana Lukin, Ellen J Scherl, Robert Battat Published in Sep 2022,...
bottom of page